BriaCell Therapeutics Corp.
$3.73
+0.02 (+0.54%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- +2.8%
- 3 Months
- +2.5%
- YTD
- -47.5%
- 1 Year
- -50.9%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 114.3%
- Largest decline max drawdown, since Aug 2025
- -80.1%
- Risk-adjusted return Sharpe ratio, 1-year
- 0.02
Own BCTX?
See how BCTX contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.